Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06585436
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-03
Brief Title:
Selective Versus Stepwise Removal of Deep Carious Lesions in Permanent Teeth Using Different Medicaments
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Selective Versus Stepwise Removal of Deep Carious Lesions in Permanent Teeth Using Different Medicaments An in Vivo Study
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study involved 54 adult patients between the ages of 18 and 50 years who had a posterior permanent tooth with a deep occlusal Class I carious lesion that extended to the inner third of the dentin D3 and divided them into two equal groups randomly N27 according to the caries removal technique group 1 SE and group 2 SW Then each main group was equally subdivided into three equal subgroups n9 according to the applied dentin dressing material as follows Subgroup 1 Nano-silver compound NSC Subgroup 2 Chitosan-loaded nano hydroxy apatite CSN-HAp Subgroup 3 Bioactive glass ionomer N-BAGGIC At the first visit both groups received the same treatment of incomplete caries excavation application of dentin dressing materials and sealing temporarily for 3-months with a glass ionomer cement GIC At the second visit the GIC reduced pulpally in SE group leaving 2 mm as base and completely removal the remaining carious lesion in SW group then re-application of same dentin dressing material on each tooth and GIC as a base Finally all cavities were restored with selective enamel etching technique after which self-etch adhesive and Nano-filled composite resin are applied according to manufacturer instructions The clinical and digital radiographic evaluations of the success and failure rates were performed at baseline 7 days 3 12 and 18-months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None